Building Successful Ecosystems in Life Sciences & Health

Powered by argenx

10:30 - 11:45

The European biotech sector is at a turning point, with the upcoming EU Biotech Act set to drive innovation and competitiveness. While Europe excels in research, it struggles to scale biotech breakthroughs into globally competitive companies. Successful ecosystems like those in the Netherlands and Massachusetts highlight the power of integrating innovation with industry, academia, and investment. To build a thriving biotech landscape, Europe must foster collaboration among policymakers, investors, and industry leaders. In this session, a high-level panel will discuss public-private partnerships, biotech financing, and regulatory challenges, with international experts sharing lessons from the Dutch, Belgium, US and Swedish biotech hubs. 

Ed Kaye
CEO & Director, Stoke Therapeutics

Mark Quick
Partner, Flerie

Jérôme Van Biervliet
Managing Director, VIB

Beth DelGiacco
VP, Corporate Communications & Investor Relations, argenx

Thomas Van Cangh
Deputy Head of Unit, European Commission

Hans Schikan
Top Team Member Life Sciences & Health, Health~Holland

Moderator

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download our event app


© Copyright 2023 by Hyphen Projects